Imaging Based Uveitis Screening for Children With Juvenile Idiopathic Arthritis
- Sponsor
- Institute of Child Health
- Study ID
- NCT05984758
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Juvenile Idiopathic Arthritis
- Uveitis, Anterior
Eligibility Criteria
- Sex
- ALL
- Age
- 2 Years - 12 Years
- Healthy Volunteers
- Not accepted
Interventions
- AS-OCT imaging — DIAGNOSTIC_TESTImage acquisition with the Optovue RTVue OCT and the Heidelberg Spectralis OCT2 machines
- Slit lamp examination — DIAGNOSTIC_TESTSLE of anterior chamber
Study Details
This study seeks to describe, for children undergoing uveitis surveillance following a new diagnosis of juvenile idiopathic arthritis, the feasibility metrics of undertaking a randomised comparative study of routine slit lamp examination (SLE) versus imaging based (anterior segment optical coherence tomography, OCT) surveillance in order to inform the development of a larger multi-centre trial.
Key Dates
- Start date
- May 1, 2024
- Status verified
- Mar 2024
- Primary completion
- Jul 1, 2026
- Completion
- Oct 1, 2026
Study Design
- Enrollment
- 80 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SCREENING
Arms
- Active Comparator: Standard careRoutine examination for uveitis with assessment of visual function followed by slit lamp examination
- Experimental: ASOCT imagingAssessment of visual function followed by image acquisition with the Optovue RTVue OCT and the Heidelberg Spectralis OCT2 machines
Primary Outcome Measure
Proportion of patients who meet the eligibility criteria [ Time Frame: 18Months ]
Central Contacts
- Ameenat Solebo+44 20 3987 2162
Related Studies
- Development of a Therapeutic Endpoint in Pediatric Rheumatologic ConditionsRecruiting · Children's National Research Institute · Washington D.C., District of Columbia
- The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior SegmentPHASE3 · Recruiting · Texas Retina Associates · Plano, Texas
- Study of Oral Upadacitinib and Subcutaneous/Intravenous Tocilizumab to Evaluate Change in Disease Activity, Adverse Events and How Drug Moves Through the Body of Pediatric and Adolescent Participants With Active Systemic Juvenile Idiopathic Arthritis.PHASE3 · Recruiting · AbbVie · Phoenix, Arizona
- Pain in Juvenile ArthritisRecruiting · Washington University School of Medicine · St Louis, Missouri